These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 16579729
1. Antiproliferative activities of parthenolide and golden feverfew extract against three human cancer cell lines. Wu C, Chen F, Rushing JW, Wang X, Kim HJ, Huang G, Haley-Zitlin V, He G. J Med Food; 2006; 9(1):55-61. PubMed ID: 16579729 [Abstract] [Full Text] [Related]
5. Effect of parthenolide on growth and apoptosis regulatory genes of human cancer cell lines. Al-Fatlawi AA, Al-Fatlawi AA, Irshad M, Rahisuddin, Ahmad A. Pharm Biol; 2015 Jan; 53(1):104-9. PubMed ID: 25289524 [Abstract] [Full Text] [Related]
6. Intra-specific variability of feverfew: correlations between parthenolide, morphological traits and seed origin. Cutlan AR, Bonilla LE, Simon JE, Erwin JE. Planta Med; 2000 Oct; 66(7):612-7. PubMed ID: 11105564 [Abstract] [Full Text] [Related]
7. Trypanosoma cruzi: antiprotozoal activity of parthenolide obtained from Tanacetum parthenium (L.) Schultz Bip. (Asteraceae, Compositae) against epimastigote and amastigote forms. Izumi E, Morello LG, Ueda-Nakamura T, Yamada-Ogatta SF, Filho BP, Cortez DA, Ferreira IC, Morgado-Díaz JA, Nakamura CV. Exp Parasitol; 2008 Mar; 118(3):324-30. PubMed ID: 17950283 [Abstract] [Full Text] [Related]
8. Parthenolide content and bioactivity of feverfew (Tanacetum parthenium (L.) Schultz-Bip.). Estimation of commercial and authenticated feverfew products. Heptinstall S, Awang DV, Dawson BA, Kindack D, Knight DW, May J. J Pharm Pharmacol; 1992 May; 44(5):391-5. PubMed ID: 1359053 [Abstract] [Full Text] [Related]
9. A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in-vitro. Groenewegen WA, Heptinstall S. J Pharm Pharmacol; 1990 Aug; 42(8):553-7. PubMed ID: 1981582 [Abstract] [Full Text] [Related]